Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy

Journal of Neurosurgery

Volumn 88, Issue 1, 1998, Pages 73-76

  Albright, A Leland ^a   Barry, Margaret J ^b   Painter, Michael J ^b   Shultz, Barbara ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NONE

Author keywords

Baclofen; Cerebral palsy; Dystonia; Movement disorder

Indexed keywords

BACLOFEN;

ADOLESCENT; ADULT; ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; DYSTONIA; HUMAN; INFUSION PUMP; INTRATHECAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031985557     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1998.88.1.0073     Document Type: Article

References (23)

1. Albright AL: Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 11 (Suppl 1):S29-S35, 1996
2. Albright AL, Barron WB, Fasick MP, et al: Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 270:2475-2477, 1993
3. Albright AL, Barry MJ, Fasick MP, et al: Continuous intrathecal baclofen infusion for symptomatic generalized dystonia. Neurosurgery 38:934-939, 1996
4. Albright AL, Barry MJ, Fasick MP, et al: Effects of continuous intrathecal baclofen infusion and selective posterior rhizotomy on upper extremity spasticity. Pediatr Neurosurg 23:82-85, 1995
5. Albright AL, Cervi A, Singletary J: Intrathecal baclofen for spasticity in cerebral palsy. JAMA 265:1418-1422, 1991
6. Alexander GE, Crutcher MD: Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266-271, 1990
7. Ashworth B: Preliminary trial of carisoprodal in multiple sclerosis. Practitioner 192:540-542, 1964
8. Burke RE, Fahn S, Gold AP: Delayed-onset dystonia in patients with "static" encephalopathy. J Neurol Neurosurg Psychiatry 43:789-797, 1980
9. Burke RE, Fahn S, Marsden CD, et al: Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35:73-77, 1985
10. Davidoff RA: Antispasticity drugs: mechanisms of action. Ann Neurol 17:107-116, 1985
11. DeLong MR, Crutcher MD, Georgopoulos AP: Primate globus pallidus and subthalamic nucleus: functional organization. J Neurophysiol 53:530-543, 1987
12. Fahn S, Marsden CD, Calne DB: Classification and investigation of dystonia, in Marsden CD, Fahn S (eds): Movement Disorders 2. London: Butterworth, 1987, pp 332-358
13. Ferraz HB, Andrade AF: Symptomatic dystonia: clinical profile of 46 Brazilian patients. Can J Neurol Sci 19:504-507, 1992
14. Greene PE, Fahn S: Baclofen in the treatment of idiopathic dystonia in children. Mov Disord 7:48-52, 1992
15. Hanson RA, Berenberg W, Byers RK: Changing motor patterns in cerebral palsy. Dev Med Child Neurol 12:309-314, 1970
16. Marsden CD: Dystonia: the spectrum of the disease, in Yahr M (ed): The Basal Ganglia. New York: Raven Press, 1976, pp 351-367
17. Narayan RD, Loubser PG, Jankovic J, et al: Intrathecal baclofen for intractable axial dystonia. Neurology 41:1141-1142, 1991
18. Otsuka M, Yanagisawa M: The effects of substance P and baclofen on motoneurons of isolated spinal cord of the newborn rat. J Exp Biol 89:201-214, 1980
19. Penn RD, Gianino JM, York MM: Intrathecal baclofen for motor disorders. Mov Disord 10:675-677, 1995
20. Saint Hilaire MH, Burke RE, Bressman SB, et al. Delayed-onset dystonia due to perinatal or early childhood asphyxia. Neurology 41:216-222, 1991
21. Tasker RR, Doorly T, Yamashiro K: Thalamotomy in generalized dystonia. Adv Neurol 50:615-631, 1988
22. Treves T, Korczyn AD: Progressive dystonia and paraparesis in cerebral palsy. Eur Neurol 25:148-153, 1986
23. 23. Zieglgansberger W, Howe JR, Sutor B: The neuropharmacology of baclofen, in Muller H, Zierski J, Penn RD (eds): Local-Spinal Therapy of Spasticity. Berlin: Springer-Verlag, 1988, pp 37-49